Table of Contents Author Guidelines Submit a Manuscript
Bioinorganic Chemistry and Applications
Volume 2007 (2007), Article ID 91078, 11 pages
http://dx.doi.org/10.1155/2007/91078
Review Article

DNA-Metallodrugs Interactions Signaled by Electrochemical Biosensors: An Overview

1Dipartimento di Scienze dell’Ambiente e della Vita, Università del Piemonte Orientale, Via Bellini 25g, Alessandria 15100, Italy
2Dipartimento di Chimica, Università di Firenze, Via della Lastruccia 3, Sesto Fiorentino Florence 50019, Italy

Received 2 April 2007; Accepted 19 June 2007

Academic Editor: Viktor Brabec

Copyright © 2007 Mauro Ravera et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Bischoff and S. Hoffmann, “DNA-binding of drugs used in medicinal therapies,” Current Medicinal Chemistry, vol. 9, no. 3, pp. 321–348, 2002. View at Google Scholar
  2. L. L. Brunton, J. S. Lazo, and K. L. Parker, Eds., Goodman & Gilman's the Pharmacological Basis of Therapeutics, McGraw-Hill, New York, NY, USA, 11th edition, 2006.
  3. B. Lippert, Ed., Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug, Wiley-VCH, New York, NY, USA, 1999.
  4. M. J. Clarke, F. Zhu, and D. R. Frasca, “Non-platinum chemotherapeutic metallopharmaceuticals,” Chemical Reviews, vol. 99, no. 9, pp. 2511–2533, 1999. View at Publisher · View at Google Scholar
  5. G. Sava, I. Capozzi, K. Clerici, G. Gagliardi, E. Alessio, and G. Mestroni, “Pharmacological control of lung metastases of solid tumours by a novel ruthenium complex,” Clinical and Experimental Metastasis, vol. 16, no. 4, pp. 371–379, 1998. View at Publisher · View at Google Scholar
  6. G. Sava, A. Bergamo, S. Zorzet et al., “Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-A,” European Journal of Cancer, vol. 38, no. 3, pp. 427–435, 2002. View at Publisher · View at Google Scholar
  7. A. Bergamo, R. Gagliardi, V. Scarcia et al., “In vitro cell cycle arrest, in vivo action on solid metastasizing tumors, and host toxicity of the antimetastatic drug NAMI-A and cisplatin,” Journal of Pharmacology and Experimental Therapeutics, vol. 289, no. 1, pp. 559–564, 1999. View at Google Scholar
  8. G. Sava, S. Zorzet, C. Turrin et al., “Dual action of NAMI-A in inhibition of solid tumor metastasis: selective targeting of metastatic cells and binding to collagen,” Clinical Cancer Research, vol. 9, no. 5, pp. 1898–1905, 2003. View at Google Scholar
  9. J. M. Rademaker-Lakhai, D. van den Bongard, D. Pluim, J. H. Beijnen, and J. H. M. Schellens, “A phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent,” Clinical Cancer Research, vol. 10, no. 11, pp. 3717–3727, 2004. View at Publisher · View at Google Scholar
  10. S. Kapitza, M. Pongratz, M. A. Jakupec et al., “Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells,” Journal of Cancer Research and Clinical Oncology, vol. 131, no. 2, pp. 101–110, 2005. View at Publisher · View at Google Scholar
  11. F. Caruso and M. Rossi, “Antitumor titanium compounds,” Mini-Reviews in Medicinal Chemistry, vol. 4, no. 1, pp. 49–60, 2004. View at Publisher · View at Google Scholar
  12. G. Lümmen, H. Sperling, H. Luboldt, T. Otto, and H. Rübben, “Phase II trial of titanocene dichloride in advanced renal-cell carcinoma,” Cancer Chemotherapy and Pharmacology, vol. 42, no. 5, pp. 415–417, 1998. View at Publisher · View at Google Scholar
  13. N. Kröger, U. R. Kleeberg, K. Mross, L. Edler, and D. K. Hossfeld, “Phase II clinical trial of titanocene dichloride in patients with metastatic breast cancer,” Onkologie, vol. 23, no. 1, pp. 60–62, 2000. View at Publisher · View at Google Scholar
  14. T. Schilling, K. B. Keppler, M. E. Heim et al., “Clinical phase I and pharmacokinetic trial of the new titanium complex budotitane,” Investigational New Drugs, vol. 13, no. 4, pp. 327–332, 1995. View at Publisher · View at Google Scholar
  15. M. Guo, H. Sun, H. J. McArdle, L. Gambling, and P. J. Sadler, “TiIV uptake and release by human serum transferrin and recognition of TiIV-transferrin by cancer cells: understanding the mechanism of action of the anticancer drug titanocene dichloride,” Biochemistry, vol. 39, no. 33, pp. 10023–10033, 2000. View at Publisher · View at Google Scholar
  16. E. Alessio, G. Mestroni, A. Bergamo, and G. Sava, “Ruthenium anticancer drugs,” in Metal Complexes in Tumor Diagnosis and as Anticancer Agents, A. Sigel and H. Sigel, Eds., vol. 42 of Metal Ions in Biological Systems, pp. 323–351, Marcel Dekker, New York, NY, USA, 2004, chapter 10. View at Google Scholar
  17. T. C. Jenkins, “Optical absorbance and fluorescence techniques for measuring DNA drug interactions,” in Drug DNA Interaction Protocols, K. R. Fox, Ed., vol. 90 of Methods in Molecular Biology, pp. 195–218, Humana Press, Totowa, NJ, USA, 1997. View at Google Scholar
  18. M. S. Searle, “NMR studies of drug-DNA interactions,” Progress in Nuclear Magnetic Resonance Spectroscopy, vol. 25, no. 5, pp. 403–480, 1993. View at Publisher · View at Google Scholar
  19. J. M. Benevides, S. A. Overman, and G. J. Thomas Jr., “Raman, polarized Raman and ultraviolet resonance Raman spectroscopy of nucleic acids and their complexes,” Journal of Raman Spectroscopy, vol. 36, no. 4, pp. 279–299, 2005. View at Publisher · View at Google Scholar
  20. A. Di Tullio, S. Reale, and F. De Angelis, “Molecular recognition by mass spectrometry,” Journal of Mass Spectrometry, vol. 40, no. 7, pp. 845–865, 2005. View at Publisher · View at Google Scholar
  21. H. P. Hopkins, “Calorimetric techniques for studying drug-DNA interactions,” in Drug DNA Interaction Protocols, K. R. Fox, Ed., vol. 90 of Methods in Molecular Biology, pp. 259–268, Humana Press, Totowa, NJ, USA, 1997. View at Google Scholar
  22. L.-P. Lin, L.-S. Huang, C.-W. Lin et al., “Determination of binding constant of DNA-binding drug to target DNA by surface plasmon resonance biosensor technology,” Current Drug Targets: Immune, Endocrine & Metabolic Disorders, vol. 5, no. 1, pp. 61–72, 2005. View at Publisher · View at Google Scholar
  23. C. Schou and N. H. H. Heegaard, “Recent applications of affinity interactions in capillary electrophoresis,” Electrophoresis, vol. 27, no. 1, pp. 44–59, 2006. View at Publisher · View at Google Scholar
  24. J. Zavaleta, D. Chinchilla, A. Brown et al., “Recent developments in affinity capillary electrophoresis: a review,” Current Analytical Chemistry, vol. 2, no. 1, pp. 35–42, 2006. View at Publisher · View at Google Scholar
  25. S. Rauf, J. J. Gooding, K. Akhtar et al., “Electrochemical approach of anticancer drugs-DNA interaction,” Journal of Pharmaceutical and Biomedical Analysis, vol. 37, no. 2, pp. 205–217, 2005. View at Publisher · View at Google Scholar
  26. E. Paleček, “Oscillographic polarography of highly polymerized deoxyribonucleic acid,” Nature, vol. 188, no. 4751, pp. 656–657, 1960. View at Publisher · View at Google Scholar
  27. D. R. Thévenot, K. Toth, R. A. Durst, and G. S. Wilson, “Electrochemical biosensors: recommended definitions and classification,” Biosensors and Bioelectronics, vol. 16, no. 1-2, pp. 121–131, 2001. View at Publisher · View at Google Scholar
  28. F. Lucarelli, G. Marrazza, A. P. F. Turner, and M. Mascini, “Carbon and gold electrodes as electrochemical transducers for DNA hybridisation sensors,” Biosensors and Bioelectronics, vol. 19, no. 6, pp. 515–530, 2004. View at Publisher · View at Google Scholar
  29. J. J. Gooding, “Electrochemical DNA hybridization biosensors,” Electroanalysis, vol. 14, no. 17, pp. 1149–1156, 2002. View at Publisher · View at Google Scholar
  30. S. Laschi and M. Mascini, “Planar electrochemical sensors for biomedical applications,” Medical Engineering and Physics, vol. 28, no. 10, pp. 934–943, 2006. View at Publisher · View at Google Scholar
  31. S. Palanti, G. Marrazza, and M. Mascini, “Electrochemical DNA probes,” Analytical Letters, vol. 29, no. 13, pp. 2309–2331, 1996. View at Google Scholar
  32. E. Paleček, “From polarography of DNA to microanalysis with nucleic acid-modified electrodes,” Electroanalysis, vol. 8, no. 1, pp. 7–14, 1996. View at Google Scholar
  33. J. Wang, G. Rivas, X. Cai et al., “DNA electrochemical biosensors for environmental monitoring. a review,” Analytica Chimica Acta, vol. 347, no. 1-2, pp. 1–8, 1997. View at Publisher · View at Google Scholar
  34. J. Zhai, H. Cui, and R. Yang, “DNA based biosensors,” Biotechnology Advances, vol. 15, no. 1, pp. 43–58, 1997. View at Publisher · View at Google Scholar
  35. E. Paleček, M. Fojta, M. Tomschik, and J. Wang, “Electrochemical biosensors for DNA hybridization and DNA damage,” Biosensors and Bioelectronics, vol. 13, no. 6, pp. 621–628, 1998. View at Publisher · View at Google Scholar
  36. E. Paleček, “Past, present and future of nucleic acids electrochemistry,” Talanta, vol. 56, no. 5, pp. 809–819, 2002. View at Publisher · View at Google Scholar
  37. A. Erdem and M. Ozsoz, “Electrochemical DNA biosensors based on DNA-drug interactions,” Electroanalysis, vol. 14, no. 14, pp. 965–974, 2002. View at Publisher · View at Google Scholar
  38. J. Wang, “Real-time electrochemical monitoring: toward green analytical chemistry,” Accounts of Chemical Research, vol. 35, no. 9, pp. 811–816, 2002. View at Publisher · View at Google Scholar
  39. M. Dequaire and A. Heller, “Screen printing of nucleic acid detecting carbon electrodes,” Analytical Chemistry, vol. 74, no. 17, pp. 4370–4377, 2002. View at Publisher · View at Google Scholar
  40. G. A. Rivas, M. L. Pedano, and N. F. Ferreyra, “Electrochemical biosensors for sequence-specific DNA detection,” Analytical Letters, vol. 38, no. 15, pp. 2653–2703, 2005. View at Publisher · View at Google Scholar
  41. M. Mehrvar and M. Abdi, “Recent developments, characteristics, and potential applications of electrochemical biosensors,” Analytical Sciences, vol. 20, no. 8, pp. 1113–1126, 2004. View at Publisher · View at Google Scholar
  42. J. P. Hart, A. Crew, E. Crouch, K. C. Honeychurch, and R. M. Pemberton, “Some recent designs and developments of screen-printed carbon electrochemical sensors/biosensors for biomedical, environmental, and industrial analyses,” Analytical Letters, vol. 37, no. 5, pp. 789–830, 2005. View at Publisher · View at Google Scholar
  43. H. Ju and H. Zhao, “Electrochemical biosensors for DNA analysis,” Frontiers in Bioscience, vol. 10, no. 1, pp. 37–46, 2005. View at Publisher · View at Google Scholar
  44. K. Kerman, M. Kobayashi, and E. Tamiya, “Recent trends in electrochemical DNA biosensor technology,” Measurement Science and Technology, vol. 15, no. 2, pp. R1–R11, 2004. View at Publisher · View at Google Scholar
  45. F. Lucarelli, L. Authier, G. Bagni et al., “DNA biosensor investigations in fish bile for use as a biomonitoring tool,” Analytical Letters, vol. 36, no. 9, pp. 1887–1901, 2003. View at Publisher · View at Google Scholar
  46. J. Wang, G. Rivas, D. Luo, X. Cai, F. S. Valera, and N. Dontha, “DNA-modified electrode for the detection of aromatic amines,” Analytical Chemistry, vol. 68, no. 24, pp. 4365–4369, 1996. View at Publisher · View at Google Scholar
  47. J. Wang, J. M. Chicarro, G. Rivas et al., “DNA biosensor for the detection of hydrazines,” Analytical Chemistry, vol. 68, no. 13, pp. 2251–2254, 1996. View at Publisher · View at Google Scholar
  48. G. Chiti, G. Marrazza, and M. Mascini, “Electrochemical DNA biosensor for environmental monitoring,” Analytica Chimica Acta, vol. 427, no. 2, pp. 155–164, 2001. View at Publisher · View at Google Scholar
  49. A. Erdem and M. Ozsoz, “Interaction of the anticancer drug epirubicin with DNA,” Analytica Chimica Acta, vol. 437, no. 1, pp. 107–114, 2001. View at Publisher · View at Google Scholar
  50. F. Lucarelli, A. Kicela, I. Palchetti, G. Marrazza, and M. Mascini, “Electrochemical DNA biosensor for analysis of wastewater samples,” Bioelectrochemistry, vol. 58, no. 1, pp. 113–118, 2002. View at Publisher · View at Google Scholar
  51. F. Lucarelli, I. Palchetti, G. Marrazza, and M. Mascini, “Electrochemical DNA biosensor as a screening tool for the detection of toxicants in water and wastewater samples,” Talanta, vol. 56, no. 5, pp. 949–957, 2002. View at Publisher · View at Google Scholar
  52. V. C. Diculescu, A.- M. C. Paquim, and A. M. O. Brett, “Electrochemical DNA sensors for detection of DNA damage,” Sensors, vol. 5, no. 6–10, pp. 377–393, 2005. View at Google Scholar
  53. J. Labuda, K. Bubnicova, L. Kovalova, M. Vanickova, J. Mattusch, and R. Wennrich, “Voltammetric detection of damage to DNA by arsenic compounds at a DNA biosensor,” Sensors, vol. 5, no. 6–10, pp. 411–423, 2005. View at Google Scholar
  54. G. Bagni, D. Osella, E. Sturchio, and M. Mascini, “Deoxyribonucleic acid (DNA) biosensors for environmental risk assessment and drug studies,” Analytica Chimica Acta, vol. 573-574, pp. 81–89, 2006. View at Publisher · View at Google Scholar
  55. G. Marrazza, G. Chiti, M. Mascini, and M. Anichini, “Detection of human apolipoprotein E genotypes by DNA electrochemical biosensor coupled with PCR,” Clinical Chemistry, vol. 46, no. 1, pp. 31–37, 2000. View at Google Scholar
  56. C. A. Rabik and M. E. Dolan, “Molecular mechanisms of resistance and toxicity associated with platinating agents,” Cancer Treatment Reviews, vol. 33, no. 1, pp. 9–23, 2007. View at Publisher · View at Google Scholar
  57. V. Brabec and J. Kasparkova, “Modifications of DNA by platinum complexes: relation to resistance of tumors to platinum antitumor drugs,” Drug Resistance Updates, vol. 8, no. 3, pp. 131–146, 2005. View at Publisher · View at Google Scholar
  58. A. Cagnini, I. Palchetti, I. Lionti, M. Mascini, and A. P. F. Turner, “Disposable ruthenized screen-printed biosensors for pesticides monitoring,” Sensors and Actuators B, vol. 24, no. 1–3, pp. 85–89, 1995. View at Publisher · View at Google Scholar
  59. G. Bagni, M. Ravera, D. Osella, and M. Mascini, “Electrochemical biosensors as a screening tool of in vitro DNA-drug interaction,” Current Pharmaceutical Analysis, vol. 1, no. 3, pp. 217–224, 2005. View at Publisher · View at Google Scholar
  60. G. Bagni, DNA biosensors for environmental risk assessment and drug studies, Ph.D. thesis, University of Florence, Florence, Italy, 2005.
  61. M. L. Pedano and G. A. Rivas, “Immobilization of DNA on glassy carbon electrodes for the development of affinity biosensors,” Biosensors and Bioelectronics, vol. 18, no. 2, pp. 269–277, 2003. View at Publisher · View at Google Scholar
  62. V. Cai, G. Rivas, P. A. M. Farias, H. Shiraishi, J. Wang, and E. Paleček, “Evaluation of different carbon electrodes for adsorptive stripping analysis of nucleic acids,” Electroanalysis, vol. 8, no. 8-9, pp. 753–758, 1996. View at Publisher · View at Google Scholar
  63. C. Xia, G. Shen, J. Jiang, and R. Yu, “Intercalation of pharmorubicin anticancer drug to DNA studied by cyclic voltammetry with analytical applications,” Analytical letters, vol. 32, no. 4, pp. 717–727, 1999. View at Google Scholar
  64. M. Ravera, S. Baracco, C. Cassino et al., “Electrochemical measurements confirm the preferential bonding of the antimetastatic complex [ImH][RuC14 (DMSO)(Im)] (NAMI-A) with the proteins and the weak interaction with nucleobases,” Inorganic Biochemistry, vol. 98, pp. 984–990, 2004. View at Publisher · View at Google Scholar
  65. M. Mascini, G. Bangi, M. L. Di Pietro, M. Ravera, S. Baracco, and D. Osella, “Electrochemical biosensor evaluation of the interaction between DNA and metallo-drugs,” Biometals, vol. 19, no. 4, pp. 409–418, 2006. View at Publisher · View at Google Scholar
  66. S. J. Berners-Price and T. G. Appleton, “The chemistry of cisplatin in aqueous solution,” in Platinum-Based Drugs in Cancer Therapy, L. R. Kelland, Ed.N. P. Farrell, Ed., pp. 3–35, Humana Press, Totowa, NJ, USA, 2000. View at Google Scholar
  67. P. M. Takahara, C. A. Frederick, and S. J. Lippard, “Crystal structure of the anticancer drug cisplatin bound to duplex DNA,” The American Chemical Society, vol. 118, no. 49, pp. 12309–12321, 1996. View at Publisher · View at Google Scholar
  68. P. M. Takahara, A. C. Rosenzweig, C. A. Frederick, and S. J. Lippard, “Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin,” Nature, vol. 377, no. 6550, pp. 649–652, 1995. View at Publisher · View at Google Scholar
  69. A. P. Silverman, W. Bu, S. M. Cohen, and S. J. Lippard, “2.4-Å crystal structure of the asymmetric platinum complex {Pt(ammine)(cyclohexylamine)}2+ bound to a dodecamer DNA duplex,” The Journal of Biological Chemistry, vol. 277, no. 51, pp. 49743–49749, 2002. View at Publisher · View at Google Scholar
  70. M. A. Jakupec, M. Galanski, and B. K. Keppler, “Tumour-inhibiting platinum complexes-state of the art and future perspectives,” Reviews of Physiology Biochemistry and Pharmacology, vol. 146, pp. 1–53, 2003. View at Publisher · View at Google Scholar
  71. W. Fery, J. D. Ranford, and P. J. Sadler, “Ring opening reactions of the anticancer drug carboplatin: NMR characterization of cis-[Pt(NH3)2(CBDCA-O)(5GMP-N7)] in solution,” Inorganic Chemistry, vol. 32, pp. 1333–1340, 1993. View at Publisher · View at Google Scholar
  72. M. Cusumano, M. L. Di Pietro, and A. Giannetto, “Relationship between binding affinity for calf-thymus DNA of [Pt(2,2bpy)(nRpy)2]2+(n=2,4) and basicity of coordinated pyridine,” Chemical Communications, no. 22, pp. 2527–2528, 1996. View at Publisher · View at Google Scholar
  73. D. P. Bancroft, C. A. Lepre, and S. J. Lippard, “Pt-195 NMR kinetics and mechanistic studies of cis-diamminedichloroplatinum and trans-diamminedichloroplatinum(II) binding to DNA,” Journal of the American Chemical Society, vol. 112, pp. 6860–6871, 1990. View at Publisher · View at Google Scholar
  74. O. Heudi, S. Mercier-Jobard, A. Cailleux, and P. Allain, “Mechanisms of reaction of L-methionine with carboplatin and oxaliplatin in different media: a comparison with cisplatin,” Biopharmaceutics and Drug Disposition, vol. 20, no. 2, pp. 107–116, 1999. View at Publisher · View at Google Scholar
  75. J. Malina, O. Novakova, B. K. Keppler, E. Alessio, and V. Brabec, “Biophysical analysis of natural, double-helical DNA modified by anticancer heterocyclic complexes of ruthenium(III) in cell-free media,” Journal of Biological Inorganic Chemistry, vol. 6, no. 4, pp. 435–445, 2001. View at Publisher · View at Google Scholar
  76. E. Gallori, C. Vettori, E. Alessio et al., “DNA as a possible target for antitumor ruthenium(III) complexes: a spectroscopic and molecular biology study of the interactions of two representative antineoplastic ruthenium(III) complexes with DNA,” Archives of Biochemistry and Biophysics, vol. 376, no. 1, pp. 156–162, 2000. View at Publisher · View at Google Scholar
  77. L. Messori, P. Orioli, D. Vullo, E. Alessio, and E. Iengo, “A spectroscopic study of the reaction of NAMI, a novel ruthenium(III) anti-neoplastic complex, with bovine serum albumin,” European Journal of Biochemistry, vol. 267, no. 4, pp. 1206–1213, 2000. View at Publisher · View at Google Scholar
  78. A. R. Timerbaev, C. G. Hartinger, S. S. Aleksenko, and B. K. Keppler, “Interactions of antitumor metallodrugs with serum proteins: advances in characterization using modern analytical methodology,” Chemical Reviews, vol. 106, no. 6, pp. 2224–2248, 2006. View at Publisher · View at Google Scholar
  79. G. Sava, E. Alessio, A. Bergamo, and G. Mestroni, “Sulfoxide ruthenium complexes: non-toxic tools for the selective treatment of solid tumour metastases,” in Topics in Biological Inorganic Chemistry, Vol. 1: Metallopharmaceuticals I DNA Interactions, pp. 144–169, Springer, Berlin, Germany, 1999. View at Google Scholar
  80. L. Y. Kuo, A. H. Liu, and T. J. Marks, “Metallocene interactions with DNA and DNA-processing enzymes,” Metal Ions in Biological Systems, vol. 33, pp. 53–85, 1996. View at Google Scholar
  81. G. Mokdsi and M. M. Harding, “Water soluble, hydrolytically stable derivatives of the antitumor drug titanocene dichloride and binding studies with nucleotides,” Journal of Organometallic Chemistry, vol. 565, no. 1-2, pp. 29–35, 1998. View at Publisher · View at Google Scholar
  82. M. M. Harding, G. Mokdsi, J. P. Mackay, M. Prodigalidad, and S. W. Lucas, “Interactions of the antitumor agent molybdocene dichloride with oligonucleotides,” Inorganic Chemistry, vol. 37, no. 10, pp. 2432–2437, 1998. View at Publisher · View at Google Scholar
  83. P. Köpf-Maier, “Intracellular localization of titanium within xenografted sensitive human tumors after treatment with the antitumor agent titanocene dichloride,” Journal of Structural Biology, vol. 105, no. 1–3, pp. 35–45, 1990. View at Google Scholar
  84. M. Guo, Z. Guo, and P. Sadler, “Titanium(IV) targets phosphoesters on nucleotides: implications for the mechanism of action of the anticancer drug titanocene dichloride,” Journal of Biological Inorganic Chemistry, vol. 6, no. 7, pp. 698–707, 2001. View at Publisher · View at Google Scholar
  85. L. A. Zwelling, T. Anderson, and K. W. Kohn, “DNA-protein and DNA interstrand cross-linking by cis- and transplatinum(II) diamminedichloride in L1210 mouse leukemia cells and relation to cytotoxicity,” Cancer Research, vol. 39, no. 2, part 1, pp. 365–369, 1979. View at Google Scholar
  86. R. J. Knox, F. Friedlos, D. A. Lydall, and J. J. Roberts, “Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA,” Cancer Research, vol. 46, no. 4, part 2, pp. 1972–1979, 1986. View at Google Scholar
  87. E. Lindauer and E. Holler, “Cellular distribution and cellular reactivity of platinum(II) complexes,” Biochemical Pharmacology, vol. 52, no. 1, pp. 7–14, 1996. View at Publisher · View at Google Scholar
  88. M. F. Pera Jr., C. J. Rawlings, and J. J. Roberts, “The role of DNA repair in the recovery of human cells from cisplatin toxicity,” Chemico-Biological Interactions, vol. 37, no. 1-2, pp. 245–261, 1981. View at Publisher · View at Google Scholar
  89. A. B. Steel, T. M. Herne, and M. J. Tarlov, “Electrochemical quantitation of DNA immobilized on gold,” Analytical Chemistry, vol. 70, no. 22, pp. 4670–4677, 1998. View at Publisher · View at Google Scholar